IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE

IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE was reported 1277 times

IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 POSTPARTUM ANXIETY 1 0.0500
1 COUGH DECREASED 3 0.0226
2 NUMB CHIN SYNDROME 1 0.0189
3 MONONUCLEOSIS HETEROPHILE TEST POSITIVE 1 0.0185
4 DEHYDROEPIANDROSTERONE INCREASED 1 0.0145
5 MYOCARDITIS INFECTIOUS 1 0.0127
6 ASTHMA LATE ONSET 1 0.0116
7 HYDROSALPINX 1 0.0109
8 CHEST EXPANSION DECREASED 1 0.0108
9 PRODUCT PRIMARY PACKAGING ISSUE 1 0.0089
10 OEDEMATOUS KIDNEY 2 0.0075
11 CAPSULE PHYSICAL ISSUE 1 0.0069
12 CARBON MONOXIDE DIFFUSING CAPACITY DECREASED 1 0.0059
13 PANCREATIC DUCT OBSTRUCTION 1 0.0056
14 EXAGGERATED STARTLE RESPONSE 1 0.0055
15 GENITAL TRACT INFLAMMATION 1 0.0050
16 PRODUCT PACKAGE ASSOCIATED INJURY 11 0.0049
17 PRODUCT DIFFICULT TO SWALLOW 5 0.0049
18 RECTAL FISSURE 3 0.0048
19 RENAL PAPILLARY NECROSIS 1 0.0047
20 VAGINAL MUCOSAL BLISTERING 1 0.0044
21 SERONEGATIVE ARTHRITIS 5 0.0044
22 ABSENCE OF IMMEDIATE TREATMENT RESPONSE 1 0.0042
23 EAR NEOPLASM MALIGNANT 1 0.0042
24 RIB DEFORMITY 1 0.0039
25 TRACHEAL OBSTRUCTION 1 0.0038
26 GASTROINTESTINAL TOXICITY 18 0.0037
27 GROWING PAINS 1 0.0037
28 SOFT TISSUE SWELLING 2 0.0035
29 DILATATION INTRAHEPATIC DUCT ACQUIRED 1 0.0034
30 PRODUCT SHAPE ISSUE 3 0.0032
31 CENTRAL SLEEP APNOEA SYNDROME 1 0.0031
32 URINE AMPHETAMINE POSITIVE 1 0.0030
33 BLOOD VISCOSITY DECREASED 1 0.0030
34 C-REACTIVE PROTEIN ABNORMAL 19 0.0030
35 CIRCUMORAL OEDEMA 1 0.0029
36 TONGUE EXFOLIATION 1 0.0028
37 TIME PERCEPTION ALTERED 1 0.0028
38 BREAST RECONSTRUCTION 1 0.0027
39 SACROILIITIS 5 0.0026
40 PULMONARY TOXICITY 18 0.0025
41 STICKY SKIN 1 0.0025
42 CAT SCRATCH DISEASE 1 0.0025
43 MANUFACTURING MATERIALS ISSUE 1 0.0025
44 VITAMIN D ABNORMAL 1 0.0024
45 CITROBACTER INFECTION 1 0.0023
46 ALLERGIC SINUSITIS 2 0.0023
47 PERINATAL DEPRESSION 1 0.0022
48 GALLBLADDER CHOLESTEROLOSIS 1 0.0022
49 INFUSION SITE HAEMATOMA 1 0.0021
50 HYPERVIGILANCE 2 0.0021
51 PRODUCT COATING ISSUE 2 0.0020
52 GASTROINTESTINAL FUNGAL INFECTION 1 0.0019
53 PRODUCT BLISTER PACKAGING ISSUE 2 0.0019
54 PRE-EXISTING CONDITION IMPROVED 12 0.0019
55 PRODUCT SIZE ISSUE 10 0.0019
56 GASTROENTERITIS ESCHERICHIA COLI 1 0.0018
57 MILK ALLERGY 1 0.0018
58 THERAPEUTIC PRODUCT EFFECT DELAYED 8 0.0018
59 BURN ORAL CAVITY 1 0.0017
60 HYPOCHLORAEMIA 2 0.0017
61 SPONDYLOARTHROPATHY 1 0.0017
62 SACRAL PAIN 1 0.0016
63 IMMUNE RECONSTITUTION SYNDROME 2 0.0015
64 SMALL INTESTINE ULCER 1 0.0015
65 PRODUCT PACKAGING DIFFICULT TO OPEN 4 0.0015
66 FASCIITIS 1 0.0015
67 FOREIGN BODY IN RESPIRATORY TRACT 2 0.0015
68 ORAL MUCOSAL DISCOLOURATION 1 0.0015
69 ALLERGIC REACTION TO EXCIPIENT 3 0.0015
70 FOREIGN BODY 6 0.0015
71 PRECANCEROUS CONDITION 1 0.0015
72 FEELING OF RELAXATION 1 0.0015
73 CONTRAINDICATED DRUG ADMINISTERED 1 0.0014
74 FALSE NEGATIVE INVESTIGATION RESULT 1 0.0014
75 CONNECTIVE TISSUE DISORDER 2 0.0014
76 TONGUE PARALYSIS 1 0.0014
77 HAEMORRHAGIC DIATHESIS 5 0.0014
78 SMALL FIBRE NEUROPATHY 1 0.0014
79 AMPHETAMINES POSITIVE 1 0.0013
80 IMPLANT SITE BRUISING 1 0.0013
81 INDIFFERENCE 1 0.0013
82 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 1 0.0013
83 DRUG SCREEN POSITIVE 10 0.0013
84 SUPERIOR SAGITTAL SINUS THROMBOSIS 1 0.0013
85 CHRONIC HEPATITIS 1 0.0012
86 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 1 0.0012
87 PERIORBITAL PAIN 1 0.0012
88 DEAFNESS TRANSITORY 1 0.0012
89 MYCOTIC ALLERGY 1 0.0012
90 LIP PRURITUS 1 0.0012
91 MENINGITIS CRYPTOCOCCAL 2 0.0011
92 AXIAL SPONDYLOARTHRITIS 1 0.0011
93 BONE EROSION 4 0.0011
94 OROPHARYNGEAL CANDIDIASIS 1 0.0011
95 EXOSTOSIS 10 0.0011
96 FIBROMA 1 0.0011
97 HAEMOCHROMATOSIS 1 0.0011
98 TENDON DISORDER 7 0.0011
99 VAGINAL DISORDER 1 0.0010
100 HAEMOPHILUS INFECTION 1 0.0010
101 SINUS HEADACHE 6 0.0010
102 SKIN OEDEMA 1 0.0010
103 EYELID PAIN 2 0.0010
104 RENAL MASS 2 0.0010
105 AXILLARY MASS 1 0.0010
106 NASAL INFLAMMATION 1 0.0009
107 INFUSION SITE MASS 1 0.0009
108 REACTION TO DRUG EXCIPIENTS 2 0.0009
109 TONSILLAR DISORDER 1 0.0009
110 JOINT INJURY 19 0.0009
111 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 26 0.0009
112 FLAT AFFECT 2 0.0009
113 OSTEOCHONDROSIS 1 0.0009
114 SINUS PAIN 2 0.0009
115 SPONDYLITIS 3 0.0008
116 PENILE SWELLING 1 0.0008
117 STERNAL FRACTURE 1 0.0008
118 HEPATOTOXICITY 18 0.0008
119 POST-ACUTE COVID-19 SYNDROME 1 0.0008
120 BLADDER DISCOMFORT 1 0.0008
121 LIP DISCOLOURATION 1 0.0008
122 PRODUCT COMPLAINT 20 0.0008
123 FEELING JITTERY 15 0.0008
124 PARANASAL SINUS HYPERSECRETION 3 0.0008
125 DACRYOSTENOSIS ACQUIRED 1 0.0008
126 POOR QUALITY DRUG ADMINISTERED 5 0.0008
127 LIP EXFOLIATION 1 0.0008
128 NASAL DISORDER 2 0.0008
129 TEMPOROMANDIBULAR JOINT SYNDROME 2 0.0007
130 DRUG EFFECT INCOMPLETE 27 0.0007
131 SKIN LACERATION 8 0.0007
132 JOINT STIFFNESS 19 0.0007
133 RASH MORBILLIFORM 2 0.0007
134 SUDDEN ONSET OF SLEEP 1 0.0007
135 ANTICONVULSANT DRUG LEVEL DECREASED 1 0.0007
136 GLUTEN SENSITIVITY 1 0.0007
137 MUTISM 1 0.0007
138 ANKYLOSING SPONDYLITIS 9 0.0007
139 SKIN STRIAE 1 0.0007
140 CHOKING 13 0.0007
141 SINUS CONGESTION 9 0.0007
142 HYPOAESTHESIA FACIAL 1 0.0007
143 BLOOD PRESSURE IMMEASURABLE 1 0.0007
144 THERAPEUTIC RESPONSE UNEXPECTED 29 0.0006
145 JOINT DESTRUCTION 1 0.0006
146 ENTHESOPATHY 1 0.0006
147 FOREIGN BODY IN THROAT 2 0.0006
148 FOOT DEFORMITY 7 0.0006
149 PRODUCT PACKAGING ISSUE 6 0.0006
150 THERAPEUTIC RESPONSE CHANGED 4 0.0006
151 OROPHARYNGEAL BLISTERING 1 0.0006
152 MITRAL VALVE PROLAPSE 1 0.0006
153 VEIN RUPTURE 1 0.0006
154 ENTEROBACTER INFECTION 1 0.0006
155 PRODUCT COLOUR ISSUE 3 0.0006
156 SENSITIVITY OF TEETH 1 0.0006
157 MICTURITION DISORDER 2 0.0006
158 MASTECTOMY 1 0.0006
159 NASAL OEDEMA 1 0.0006
160 SMALL INTESTINAL PERFORATION 1 0.0005
161 IMPATIENCE 1 0.0005
162 INTENTIONAL MISUSE 1 0.0005
163 PSORIATIC ARTHROPATHY 21 0.0005
164 NASAL SEPTUM DEVIATION 1 0.0005
165 MULTI-ORGAN DISORDER 1 0.0005
166 ENERGY INCREASED 3 0.0005
167 SUSPECTED COUNTERFEIT PRODUCT 2 0.0005
168 ANORECTAL DISORDER 1 0.0005
169 SYNOVITIS 9 0.0005
170 ARTERIOSPASM CORONARY 2 0.0005
171 REBOUND ATOPIC DERMATITIS 1 0.0005
172 COMPULSIVE SHOPPING 1 0.0005
173 SECRETION DISCHARGE 6 0.0005
174 NASAL DRYNESS 3 0.0005
175 ATRIAL TACHYCARDIA 1 0.0005
176 POOR QUALITY PRODUCT ADMINISTERED 5 0.0005
177 PURULENT DISCHARGE 2 0.0005
178 EXOPHTHALMOS 1 0.0005
179 AMYOTROPHIC LATERAL SCLEROSIS 1 0.0005
180 INFUSION SITE BRUISING 1 0.0005
181 GASTRIC BYPASS 1 0.0005
182 ANKLE FRACTURE 7 0.0005
183 GASTROINTESTINAL ULCER 1 0.0005
184 LIP SWELLING 15 0.0004
185 CALCINOSIS 1 0.0004
186 THERAPY NON-RESPONDER 20 0.0004
187 DRUG EFFECT DELAYED 2 0.0004
188 MUSCULOSKELETAL PAIN 23 0.0004
189 ORAL PRURITUS 1 0.0004
190 JOINT EFFUSION 3 0.0004
191 REACTION TO EXCIPIENT 1 0.0004
192 HAEMANGIOMA 1 0.0004
193 BREAKTHROUGH PAIN 1 0.0004
194 ARTHRITIS INFECTIVE 2 0.0004
195 PULMONARY INFARCTION 1 0.0004
196 MYOPIA 1 0.0004
197 URINE FLOW DECREASED 1 0.0004
198 POOR QUALITY SLEEP 9 0.0004
199 PARAESTHESIA ORAL 6 0.0004
200 WRONG DOSE 1 0.0004
201 LYMPHADENITIS 1 0.0004
202 BREATH ODOUR 1 0.0004
203 HYPERVOLAEMIA 2 0.0004
204 SINUS DISORDER 8 0.0004
205 EYE SWELLING 15 0.0004
206 MUSCULOSKELETAL STIFFNESS 35 0.0004
207 PAROSMIA 3 0.0004
208 ARTHROPATHY 22 0.0004
209 DRUG TOLERANCE 2 0.0004
210 TUBERCULIN TEST POSITIVE 1 0.0004
211 ANGLE CLOSURE GLAUCOMA 1 0.0004
212 INCREASED UPPER AIRWAY SECRETION 2 0.0004
213 TENDERNESS 4 0.0004
214 POLYARTHRITIS 2 0.0004
215 SKIN DISCOMFORT 1 0.0004
216 GAMBLING DISORDER 1 0.0004
217 PHARYNGITIS STREPTOCOCCAL 4 0.0004
218 PRODUCT TASTE ABNORMAL 5 0.0004
219 FOOT FRACTURE 7 0.0004
220 EAR CONGESTION 1 0.0004
221 GASTRIC PERFORATION 1 0.0004
222 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 26 0.0004
223 ORAL FUNGAL INFECTION 1 0.0004
224 HYPOMENORRHOEA 1 0.0004
225 CONTRAINDICATED PRODUCT ADMINISTERED 11 0.0004
226 DRUG SCREEN FALSE POSITIVE 1 0.0004
227 JOINT LOCK 1 0.0004
228 DRUG INTOLERANCE 34 0.0004
229 LIP PAIN 1 0.0003
230 EYELID MARGIN CRUSTING 1 0.0003
231 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
232 EYELID OEDEMA 4 0.0003
233 FEELING OF BODY TEMPERATURE CHANGE 2 0.0003
234 EXPIRED PRODUCT ADMINISTERED 11 0.0003
235 MASTICATION DISORDER 1 0.0003
236 DRUG ABUSER 2 0.0003
237 JOINT SWELLING 39 0.0003
238 EYELIDS PRURITUS 1 0.0003
239 SWELLING OF EYELID 2 0.0003
240 NON-CARDIAC CHEST PAIN 1 0.0003
241 PNEUMONIA VIRAL 1 0.0003
242 EXPOSURE TO TOXIC AGENT 1 0.0003
243 THERAPEUTIC PRODUCT EFFECT DECREASED 14 0.0003
244 CARDIAC FLUTTER 2 0.0003
245 VULVOVAGINAL DRYNESS 1 0.0003
246 RENAL TUBULAR NECROSIS 3 0.0003
247 COELIAC DISEASE 3 0.0003
248 LISTLESS 1 0.0003
249 PRODUCT FORMULATION ISSUE 2 0.0003
250 SKIN MASS 2 0.0003
251 WOUND DEHISCENCE 1 0.0003
252 CLOSTRIDIAL INFECTION 1 0.0003
253 REGURGITATION 1 0.0003
254 INFLAMMATION 15 0.0003
255 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
256 TACHYPHRENIA 1 0.0003
257 POLYMENORRHOEA 1 0.0003
258 ORAL DISCOMFORT 4 0.0003
259 EXTRASYSTOLES 2 0.0003
260 CAROTID ARTERY STENOSIS 1 0.0003
261 CARPAL TUNNEL SYNDROME 4 0.0003
262 EAR PRURITUS 1 0.0003
263 NEOPLASM MALIGNANT 19 0.0003
264 HANGOVER 1 0.0003
265 DUODENAL ULCER 2 0.0003
266 JAUNDICE CHOLESTATIC 1 0.0003
267 GLOSSITIS 1 0.0003
268 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
269 FRUSTRATION 1 0.0003
270 TREATMENT FAILURE 23 0.0003
271 ALCOHOL USE 1 0.0003
272 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
273 HYPOAESTHESIA ORAL 4 0.0003
274 MICTURITION URGENCY 3 0.0003
275 GASTRIC INFECTION 1 0.0003
276 DISSOCIATION 2 0.0003
277 FOOD ALLERGY 2 0.0003
278 APHTHOUS ULCER 2 0.0003
279 FAECES HARD 1 0.0003
280 HAEMORRHOIDS 5 0.0003
281 EPIGASTRIC DISCOMFORT 1 0.0003
282 ARTHRITIS 20 0.0003
283 PRODUCT USE COMPLAINT 4 0.0003
284 NASAL DISCOMFORT 2 0.0003
285 PRODUCT PRESCRIBING ERROR 6 0.0003
286 GINGIVAL PAIN 2 0.0003
287 CEREBRAL ATROPHY 1 0.0003
288 PRODUCT PHYSICAL ISSUE 5 0.0002
289 VITAMIN B12 DEFICIENCY 1 0.0002
290 HOMICIDAL IDEATION 1 0.0002
291 AORTIC DISSECTION 1 0.0002
292 PSYCHOMOTOR HYPERACTIVITY 4 0.0002
293 SKIN DISORDER 8 0.0002
294 NASAL CONGESTION 14 0.0002
295 TONGUE DISCOMFORT 1 0.0002
296 CARDIAC FAILURE CHRONIC 1 0.0002
297 SHOULDER OPERATION 1 0.0002
298 MYDRIASIS 3 0.0002
299 TENSION HEADACHE 1 0.0002
300 DEVICE OPERATIONAL ISSUE 1 0.0002
301 ANURIA 2 0.0002
302 MUSCLE STRAIN 2 0.0002
303 HORDEOLUM 1 0.0002
304 FAECES DISCOLOURED 5 0.0002
305 CHAPPED LIPS 1 0.0002
306 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
307 TONGUE DISCOLOURATION 1 0.0002
308 DRUG INEFFECTIVE 298 0.0002
309 FACIAL PAIN 2 0.0002
310 IMPLANT SITE PAIN 1 0.0002
311 SUSPECTED OFF LABEL USE 1 0.0002
312 DYSPHAGIA 21 0.0002
313 LIP DRY 2 0.0002
314 IMPAIRED GASTRIC EMPTYING 3 0.0002
315 RHINORRHOEA 14 0.0002
316 LOCALISED OEDEMA 1 0.0002
317 SWELLING FACE 14 0.0002
318 VAGINAL INFECTION 1 0.0002
319 THERAPEUTIC RESPONSE SHORTENED 7 0.0002
320 VIRAL UPPER RESPIRATORY TRACT INFECTION 1 0.0002
321 DISEASE RECURRENCE 10 0.0002
322 FINGER DEFORMITY 1 0.0002
323 HORMONE LEVEL ABNORMAL 1 0.0002
324 ORAL HERPES 4 0.0002
325 DRUG EFFECT DECREASED 11 0.0002
326 NASAL POLYPS 1 0.0002
327 EUPHORIC MOOD 2 0.0002
328 INITIAL INSOMNIA 2 0.0002
329 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
330 HEART RATE INCREASED 19 0.0002
331 TONSILLITIS 1 0.0002
332 RESTLESSNESS 7 0.0002
333 PRODUCT ODOUR ABNORMAL 2 0.0002
334 SENSITIVITY TO WEATHER CHANGE 1 0.0002
335 OSTEOARTHRITIS 8 0.0002
336 RENAL PAIN 2 0.0002
337 HYPERSENSITIVITY 35 0.0002
338 ANORECTAL DISCOMFORT 1 0.0002
339 PALPITATIONS 22 0.0002
340 INSOMNIA 50 0.0002
341 ANAL FISSURE 1 0.0002
342 BRUXISM 1 0.0002
343 ERYTHEMA OF EYELID 1 0.0002
344 ASPIRATION 2 0.0002
345 JAW DISORDER 1 0.0002
346 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 10 0.0002
347 GASTROINTESTINAL PAIN 2 0.0002
348 CHOKING SENSATION 1 0.0002
349 HEART RATE ABNORMAL 1 0.0002
350 SOMNOLENCE 36 0.0002
351 SNEEZING 4 0.0002
352 NEPHROPATHY TOXIC 2 0.0002
353 OCULAR DISCOMFORT 2 0.0002
354 GENERALISED ERYTHEMA 1 0.0002
355 DYSGEUSIA 13 0.0002
356 NEUROLOGICAL SYMPTOM 1 0.0002
357 VISUAL DISTURBANCE 1 0.0002
358 GASTRIC HAEMORRHAGE 2 0.0002
359 MOUTH SWELLING 1 0.0002
360 METABOLIC DISORDER 1 0.0002
361 POST PROCEDURAL HAEMORRHAGE 2 0.0002
362 CONDITION AGGRAVATED 52 0.0002
363 SWELLING 16 0.0002
364 SPINAL PAIN 2 0.0002
365 HYPERCHLORHYDRIA 1 0.0002
366 DECREASED INTEREST 1 0.0002
367 PERIPHERAL SWELLING 26 0.0002
368 BLOOD IRON DECREASED 2 0.0002
369 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
370 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1 0.0002
371 CHOLANGITIS 1 0.0002
372 PHARYNGITIS 2 0.0002
373 URTICARIA 27 0.0002
374 INFUSION SITE EXTRAVASATION 1 0.0002
375 EPISTAXIS 12 0.0002
376 SWOLLEN TONGUE 5 0.0002
377 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
378 PHOTOPHOBIA 3 0.0002
379 INFECTION 23 0.0002
380 HEAD INJURY 5 0.0002
381 PRODUCT USE IN UNAPPROVED INDICATION 39 0.0002
382 INJECTION SITE IRRITATION 2 0.0002
383 SINUSITIS 16 0.0002
384 HAEMOGLOBIN ABNORMAL 1 0.0002
385 INCOHERENT 1 0.0002
386 HERPES SIMPLEX 1 0.0002
387 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
388 DEAFNESS 4 0.0002
389 PRODUCT PREPARATION ISSUE 1 0.0002
390 FEELING ABNORMAL 36 0.0002
391 EYE HAEMORRHAGE 2 0.0001
392 RHEUMATOID ARTHRITIS 17 0.0001
393 POST-TRAUMATIC STRESS DISORDER 1 0.0001
394 INTENTIONAL PRODUCT MISUSE 13 0.0001
395 EXTRA DOSE ADMINISTERED 6 0.0001
396 WRONG PRODUCT ADMINISTERED 1 0.0001
397 ANGER 5 0.0001
398 UVEITIS 2 0.0001
399 LIMB INJURY 4 0.0001
400 ABNORMAL LOSS OF WEIGHT 1 0.0001
401 GINGIVAL BLEEDING 2 0.0001
402 CROHN'S DISEASE 1 0.0001
403 FORMICATION 1 0.0001
404 HUNGER 2 0.0001
405 NECK PAIN 8 0.0001
406 DIVERTICULUM 1 0.0001
407 RETCHING 3 0.0001
408 BRONCHOSPASM 2 0.0001
409 PANIC REACTION 1 0.0001
410 TONGUE DISORDER 1 0.0001
411 ANOSMIA 2 0.0001
412 RASH PUSTULAR 1 0.0001
413 UTERINE LEIOMYOMA 1 0.0001
414 ORAL DISORDER 1 0.0001
415 FEELING DRUNK 1 0.0001
416 SUNBURN 1 0.0001
417 NERVOUSNESS 7 0.0001
418 PEMPHIGOID 1 0.0001
419 APHASIA 4 0.0001
420 ABDOMINAL PAIN UPPER 27 0.0001
421 INSURANCE ISSUE 2 0.0001
422 BLOOD CHOLESTEROL INCREASED 6 0.0001
423 SLEEP DISORDER 9 0.0001
424 FURUNCLE 1 0.0001
425 BLOOD ALBUMIN DECREASED 1 0.0001
426 CYSTITIS 4 0.0001
427 PAIN IN EXTREMITY 37 0.0001
428 MOBILITY DECREASED 9 0.0001
429 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
430 HIP FRACTURE 4 0.0001
431 BLOOD PRESSURE INCREASED 19 0.0001
432 STENT PLACEMENT 1 0.0001
433 FRUSTRATION TOLERANCE DECREASED 1 0.0001
434 NEURALGIA 3 0.0001
435 ABNORMAL FAECES 1 0.0001
436 HICCUPS 1 0.0001
437 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
438 HAIR DISORDER 1 0.0001
439 MENSTRUAL DISORDER 1 0.0001
440 HEMIPLEGIA 1 0.0001
441 NASOPHARYNGITIS 22 0.0001
442 ABDOMINAL DISCOMFORT 20 0.0001
443 DRUG USE DISORDER 1 0.0001
444 INFUSION SITE ERYTHEMA 1 0.0001
445 FACE OEDEMA 2 0.0001
446 SKIN PLAQUE 1 0.0001
447 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
448 FACIAL PARALYSIS 1 0.0001
449 ANAPHYLACTIC SHOCK 3 0.0001
450 PARANOIA 2 0.0001
451 PSYCHOLOGICAL TRAUMA 1 0.0001
452 RASH GENERALISED 3 0.0001
453 RESPIRATORY TRACT INFECTION 3 0.0001
454 LOCAL SWELLING 2 0.0001
455 DIZZINESS 57 0.0001
456 GROIN PAIN 1 0.0001
457 COLD SWEAT 2 0.0001
458 PRODUCT COMMUNICATION ISSUE 1 0.0001
459 LUNG INFILTRATION 1 0.0001
460 WRONG DRUG ADMINISTERED 1 0.0001
461 THROAT IRRITATION 5 0.0001
462 GASTROENTERITIS VIRAL 2 0.0001
463 ARTHRALGIA 46 0.0001
464 TOOTHACHE 2 0.0001
465 OPTIC NEURITIS 1 0.0001
466 GRAND MAL CONVULSION 1 0.0001
467 PROCEDURAL PAIN 3 0.0001
468 OROPHARYNGEAL PAIN 10 0.0001
469 PRODUCT DISTRIBUTION ISSUE 1 0.0001
470 BACTERIAL INFECTION 2 0.0001
471 EYE PAIN 6 0.0001
472 ARTERIOSCLEROSIS 1 0.0001
473 HALLUCINATION 8 0.0001
474 SPUTUM DISCOLOURED 1 0.0001
475 BLOOD URINE PRESENT 2 0.0001
476 SLEEP APNOEA SYNDROME 2 0.0001
477 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1 0.0001
478 EAR PAIN 2 0.0001
479 HAEMATOCRIT DECREASED 2 0.0001
480 HYPOAESTHESIA 15 0.0001
481 DRY EYE 5 0.0001
482 HEADACHE 62 0.0001
483 PRURITUS 38 0.0001
484 VAGINAL DISCHARGE 1 0.0001
485 HYPOTHERMIA 1 0.0001
486 INFLUENZA 11 0.0001
487 FEEDING DISORDER 2 0.0001
488 EYELID PTOSIS 1 0.0001
489 DRY THROAT 1 0.0001
490 SLUGGISHNESS 1 0.0001
491 SKIN BURNING SENSATION 7 0.0001
492 EAR DISCOMFORT 1 0.0001
493 INFLUENZA LIKE ILLNESS 8 0.0001
494 TEMPERATURE INTOLERANCE 1 0.0001
495 POOR VENOUS ACCESS 1 0.0001
496 VENTRICULAR EXTRASYSTOLES 1 0.0001
497 EYE DISCHARGE 1 0.0001
498 PRODUCT USE ISSUE 18 0.0001
499 FOLLICULITIS 1 0.0001
500 SCRATCH 1 0.0001
501 MOOD SWINGS 3 0.0001
502 EATING DISORDER 2 0.0001
503 HEREDITARY ANGIOEDEMA 1 0.0001
504 LIVER FUNCTION TEST INCREASED 2 0.0001
505 BREAST CANCER METASTATIC 1 0.0001
506 BALANCE DISORDER 8 0.0001
507 UNEVALUABLE EVENT 7 0.0001
508 PULMONARY THROMBOSIS 1 0.0001
509 EYE DISORDER 3 0.0001
510 DEPENDENCE 5 0.0001
511 ANGIOEDEMA 4 0.0001
512 NERVE INJURY 1 0.0001
513 DRY SKIN 12 0.0001
514 GAIT INABILITY 3 0.0001
515 MALNUTRITION 1 0.0001
516 SKIN INFECTION 1 0.0001
517 BLISTER 5 0.0001
518 BLOOD CALCIUM DECREASED 1 0.0001
519 MYOCARDIAL ISCHAEMIA 1 0.0001
520 DERMATITIS CONTACT 1 0.0001
521 MYOCARDITIS 1 0.0001
522 MUSCLE TWITCHING 2 0.0001
523 NIGHTMARE 3 0.0001
524 MALAISE 38 0.0001
525 DRY MOUTH 7 0.0001
526 MADAROSIS 1 0.0001
527 HYPERKALAEMIA 3 0.0001
528 WHEEZING 5 0.0001
529 OCULAR HYPERAEMIA 4 0.0001
530 CHOLECYSTITIS 1 0.0001
531 PRODUCTIVE COUGH 4 0.0001
532 BLOOD PRESSURE FLUCTUATION 2 0.0001
533 CRYING 3 0.0001
534 MENTAL IMPAIRMENT 2 0.0001
535 BURSITIS 1 0.0001
536 PANIC ATTACK 3 0.0001
537 FIBROMYALGIA 2 0.0001
538 INJECTION SITE EXTRAVASATION 1 0.0001
539 NAUSEA 64 0.0001
540 HAIR COLOUR CHANGES 1 0.0001
541 AGEUSIA 2 0.0001
542 INTENTIONAL PRODUCT USE ISSUE 7 0.0001
543 COVID-19 14 0.0001
544 DYSARTHRIA 3 0.0001
545 VOMITING 37 0.0001
546 TREMOR 13 0.0001
547 DEVICE DEPLOYMENT ISSUE 1 0.0001
548 HEPATITIS 2 0.0001
549 ROTATOR CUFF SYNDROME 1 0.0001
550 ILLNESS 8 0.0001
551 INFUSION SITE PAIN 1 0.0001
552 ANOREXIA 1 0.0001
553 UNRESPONSIVE TO STIMULI 2 0.0001
554 ANXIETY 22 0.0001
555 PLATELET COUNT INCREASED 1 0.0001
556 HAEMORRHAGE 8 0.0001
557 SEDATION 2 0.0001
558 HAND DEFORMITY 1 0.0001
559 ANHEDONIA 2 0.0001
560 DYSPNOEA 43 0.0001
561 ORAL CANDIDIASIS 1 0.0001
562 IMMUNE SYSTEM DISORDER 1 0.0001
563 SARS-COV-2 TEST POSITIVE 1 0.0001
564 DRUG INTERACTION 12 0.0001
565 CHEST PAIN 14 0.0001
566 INFUSION RELATED REACTION 5 0.0001
567 ADVERSE REACTION 1 0.0001
568 INJECTION SITE HAEMORRHAGE 6 0.0001
569 HAIR TEXTURE ABNORMAL 1 0.0001
570 DEPRESSION 17 0.0001
571 MALIGNANT MELANOMA 1 0.0001
572 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 15 0.0001
573 THROAT TIGHTNESS 2 0.0001
574 PRODUCT QUALITY ISSUE 10 0.0001
575 BACK PAIN 17 0.0001
576 CORONARY ARTERY OCCLUSION 1 0.0001
577 PERIPHERAL COLDNESS 1 0.0001
578 HAEMATOCHEZIA 4 0.0001
579 ABNORMAL DREAMS 2 0.0001
580 DIVERTICULITIS 2 0.0001
581 FEELING COLD 2 0.0001
582 ROAD TRAFFIC ACCIDENT 3 0.0001
583 MASS 1 0.0001
584 BLOOD TEST ABNORMAL 1 0.0001
585 SKIN EXFOLIATION 6 0.0001
586 HYPERTENSION 15 0.0001
587 SEASONAL ALLERGY 1 0.0001
588 LOSS OF CONSCIOUSNESS 9 0.0001
589 HYPERHIDROSIS 9 0.0001
590 ANGINA PECTORIS 2 0.0001
591 HYPERSOMNIA 2 0.0001
592 HERPES ZOSTER 4 0.0001
593 IMPAIRED QUALITY OF LIFE 1 0.0001
594 OVERDOSE 15 0.0001
595 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
596 APATHY 1 0.0001
597 LABORATORY TEST ABNORMAL 2 0.0001
598 COUGH 19 0.0001
599 PSYCHOTIC DISORDER 2 0.0001
600 IMMUNODEFICIENCY 1 0.0001
601 HAEMORRHAGE INTRACRANIAL 1 0.0001
602 RESPIRATORY DISORDER 2 0.0001
603 RASH 29 0.0001
604 EMOTIONAL DISTRESS 8 0.0001
605 ECONOMIC PROBLEM 1 0.0001
606 VERTIGO 4 0.0001
607 SKIN DISCOLOURATION 3 0.0001
608 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
609 THYROID DISORDER 1 0.0001
610 EMOTIONAL DISORDER 2 0.0001
611 MUSCULOSKELETAL CHEST PAIN 1 0.0001
612 LUNG INFECTION 1 0.0001
613 CARDIAC DISORDER 6 0.0001
614 HALLUCINATION, AUDITORY 1 0.0001
615 MIGRAINE 6 0.0001
616 OBESITY 1 0.0001
617 RASH ERYTHEMATOUS 3 0.0001
618 SCIATICA 1 0.0001
619 SENSORY DISTURBANCE 1 0.0001
620 GASTROOESOPHAGEAL REFLUX DISEASE 5 0.0001
621 NIGHT SWEATS 2 0.0001
622 ASTHMA 7 0.0001
623 PAIN 38 0.0001
624 MUSCLE TIGHTNESS 1 0.0001
625 ATRIAL FIBRILLATION 6 0.0001
626 BLOOD POTASSIUM INCREASED 1 0.0001
627 METASTASES TO BONE 1 0.0001
628 VENTRICULAR TACHYCARDIA 1 0.0001
629 DRUG LEVEL INCREASED 1 0.0001
630 VIRAL INFECTION 2 0.0001
631 FUNGAL INFECTION 2 0.0001
632 DEHYDRATION 8 0.0001
633 URINARY RETENTION 2 0.0001
634 EYE PRURITUS 2 0.0001
635 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
636 METRORRHAGIA 1 0.0001
637 SCAR 1 0.0001
638 MEMORY IMPAIRMENT 8 0.0001
639 MUSCULOSKELETAL DISCOMFORT 1 0.0001
640 FATIGUE 45 0.0001
641 GAIT DISTURBANCE 11 0.0001
642 RASH MACULAR 2 0.0001
643 BURNING SENSATION 4 0.0001
644 AMENORRHOEA 1 0.0001
645 HEART RATE DECREASED 2 0.0001
646 METASTASES TO LIVER 1 0.0001
647 HEAD DISCOMFORT 1 0.0001
648 GALLBLADDER DISORDER 1 0.0001
649 DRUG DEPENDENCE 9 0.0001
650 THIRST 1 0.0001
651 GOUT 1 0.0001
652 OSTEOMYELITIS 1 0.0001
653 PELVIC PAIN 1 0.0001
654 CONSTIPATION 12 0.0001
655 SUICIDAL IDEATION 5 0.0001
656 MUSCLE SPASMS 10 0.0001
657 DYSURIA 2 0.0001
658 ANAPHYLACTIC REACTION 3 0.0001
659 PSORIASIS 7 0.0001
660 MIDDLE INSOMNIA 1 0.0001
661 ERYTHEMA 11 0.0001
662 ASTHENIA 20 0.0001
663 DYSPNOEA EXERTIONAL 2 0.0001
664 HOT FLUSH 4 0.0001
665 INTESTINAL OBSTRUCTION 2 0.0001
666 GASTRIC ULCER 1 0.0001
667 PROTEINURIA 1 0.0001
668 INCORRECT DOSE ADMINISTERED 12 0.0001
669 MUSCULOSKELETAL DISORDER 1 0.0001
670 CONVULSION 3 0.0001
671 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
672 PRODUCT SUBSTITUTION ISSUE 3 0.0001
673 GLAUCOMA 1 0.0001
674 HERNIA 1 0.0001
675 ERUCTATION 1 0.0001
676 DECREASED APPETITE 12 0.0001
677 VISION BLURRED 7 0.0001
678 KIDNEY INFECTION 1 0.0001
679 DYSPEPSIA 5 0.0001
680 DISABILITY 1 0.0001
681 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
682 DISORIENTATION 2 0.0001
683 CATARACT 3 0.0001
684 UPPER LIMB FRACTURE 1 0.0001
685 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 9 0.0000
686 SPINAL FRACTURE 1 0.0000
687 IRRITABILITY 3 0.0000
688 THROMBOSIS 4 0.0000
689 CONFUSIONAL STATE 8 0.0000
690 ILL-DEFINED DISORDER 3 0.0000
691 DYSKINESIA 2 0.0000
692 OFF LABEL USE 43 0.0000
693 NEUTROPHIL COUNT DECREASED 2 0.0000
694 BODY TEMPERATURE INCREASED 1 0.0000
695 RIB FRACTURE 1 0.0000
696 ACCIDENTAL EXPOSURE TO PRODUCT 5 0.0000
697 FALL 16 0.0000
698 POLLAKIURIA 2 0.0000
699 INTENTIONAL DRUG MISUSE 1 0.0000
700 HALLUCINATION, VISUAL 1 0.0000
701 IMPAIRED WORK ABILITY 1 0.0000
702 IRRITABLE BOWEL SYNDROME 1 0.0000
703 DIARRHOEA 30 0.0000
704 HYPOACUSIS 2 0.0000
705 PRURITUS GENERALISED 1 0.0000
706 DEEP VEIN THROMBOSIS 3 0.0000
707 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
708 WHITE BLOOD CELL COUNT DECREASED 5 0.0000
709 VAGINAL HAEMORRHAGE 2 0.0000
710 MENTAL DISORDER 2 0.0000
711 PRODUCT DOSE OMISSION 3 0.0000
712 TACHYCARDIA 4 0.0000
713 TOOTH DISORDER 1 0.0000
714 RASH PAPULAR 1 0.0000
715 PARAESTHESIA 7 0.0000
716 CHROMATURIA 1 0.0000
717 HEART RATE IRREGULAR 1 0.0000
718 HEPATIC ENZYME INCREASED 3 0.0000
719 NEPHROLITHIASIS 2 0.0000
720 TINNITUS 2 0.0000
721 SHOCK 1 0.0000
722 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 2 0.0000
723 PULMONARY EMBOLISM 4 0.0000
724 NEUROPATHY PERIPHERAL 4 0.0000
725 DIABETIC KETOACIDOSIS 1 0.0000
726 PRESYNCOPE 1 0.0000
727 CEREBRAL INFARCTION 1 0.0000
728 AGITATION 3 0.0000
729 ALOPECIA 8 0.0000
730 BRONCHITIS 3 0.0000
731 OSTEONECROSIS OF JAW 1 0.0000
732 WEIGHT INCREASED 9 0.0000
733 ACNE 3 0.0000
734 HAEMATEMESIS 1 0.0000
735 WEIGHT DECREASED 11 0.0000
736 DIABETES MELLITUS 3 0.0000
737 HYPOPHAGIA 1 0.0000
738 EXPOSURE VIA SKIN CONTACT 1 0.0000
739 PHARMACEUTICAL PRODUCT COMPLAINT 1 0.0000
740 DIPLOPIA 1 0.0000
741 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
742 ABDOMINAL DISTENSION 4 0.0000
743 MUCOSAL INFLAMMATION 1 0.0000
744 SPEECH DISORDER 2 0.0000
745 EAR INFECTION 1 0.0000
746 PYREXIA 13 0.0000
747 BREAST CANCER FEMALE 1 0.0000
748 MENSTRUATION IRREGULAR 1 0.0000
749 FEAR 1 0.0000
750 DISTURBANCE IN ATTENTION 2 0.0000
751 RASH PRURITIC 2 0.0000
752 OEDEMA 2 0.0000
753 PALLOR 1 0.0000
754 SKIN LESION 1 0.0000
755 MENTAL STATUS CHANGES 1 0.0000
756 HYPONATRAEMIA 2 0.0000
757 CEREBROVASCULAR ACCIDENT 6 0.0000
758 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
759 MYALGIA 6 0.0000
760 FLATULENCE 2 0.0000
761 INTENTIONAL DOSE OMISSION 1 0.0000
762 RED BLOOD CELL COUNT DECREASED 1 0.0000
763 LETHARGY 2 0.0000
764 BONE PAIN 2 0.0000
765 SURGERY 2 0.0000
766 ACUTE MYOCARDIAL INFARCTION 1 0.0000
767 URINARY INCONTINENCE 1 0.0000
768 GASTROINTESTINAL DISORDER 3 0.0000
769 BLOOD POTASSIUM DECREASED 1 0.0000
770 LACRIMATION INCREASED 1 0.0000
771 THERAPEUTIC RESPONSE DECREASED 2 0.0000
772 STOMATITIS 2 0.0000
773 DISCOMFORT 2 0.0000
774 EPILEPSY 1 0.0000
775 INJECTION SITE RASH 1 0.0000
776 LIMB DISCOMFORT 1 0.0000
777 NERVOUS SYSTEM DISORDER 1 0.0000
778 HYPOTHYROIDISM 1 0.0000
779 INTENTIONAL OVERDOSE 2 0.0000
780 CONTUSION 3 0.0000
781 LACTIC ACIDOSIS 1 0.0000
782 BLOOD CREATININE INCREASED 2 0.0000
783 CHOLELITHIASIS 1 0.0000
784 TYPE 2 DIABETES MELLITUS 1 0.0000
785 CHEST DISCOMFORT 3 0.0000
786 GASTRIC DISORDER 1 0.0000
787 DELIRIUM 1 0.0000
788 NEOPLASM PROGRESSION 1 0.0000
789 DEVICE MALFUNCTION 2 0.0000
790 LYMPHADENOPATHY 1 0.0000
791 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
792 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
793 CEREBRAL HAEMORRHAGE 1 0.0000
794 UNDERDOSE 2 0.0000
795 ACCIDENTAL OVERDOSE 1 0.0000
796 HEPATIC FUNCTION ABNORMAL 1 0.0000
797 COLITIS 1 0.0000
798 SEIZURE 3 0.0000
799 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
800 CHILLS 3 0.0000
801 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
802 ABNORMAL BEHAVIOUR 1 0.0000
803 INJECTION SITE BRUISING 2 0.0000
804 OEDEMA PERIPHERAL 3 0.0000
805 COMPLETED SUICIDE 2 0.0000
806 WITHDRAWAL SYNDROME 1 0.0000
807 PRODUCT DOSE OMISSION ISSUE 7 0.0000
808 RENAL FAILURE ACUTE 1 0.0000
809 RECTAL HAEMORRHAGE 1 0.0000
810 SEPTIC SHOCK 1 0.0000
811 MYOCARDIAL INFARCTION 4 0.0000
812 RENAL FAILURE 3 0.0000
813 LIVER DISORDER 1 0.0000
814 DEVICE ISSUE 2 0.0000
815 ADVERSE EVENT 2 0.0000
816 HYPOKALAEMIA 1 0.0000
817 PNEUMONIA 7 0.0000
818 ABDOMINAL PAIN 5 0.0000
819 RENAL DISORDER 1 0.0000
820 COGNITIVE DISORDER 1 0.0000
821 ARRHYTHMIA 1 0.0000
822 SYNCOPE 2 0.0000
823 AGGRESSION 1 0.0000
824 HAEMOGLOBIN DECREASED 2 0.0000
825 DEPRESSED MOOD 1 0.0000
826 BRADYCARDIA 1 0.0000
827 PLATELET COUNT DECREASED 2 0.0000
828 TREATMENT NONCOMPLIANCE 1 0.0000
829 DRUG DOSE OMISSION 3 0.0000
830 MEDICATION ERROR 1 0.0000
831 PANCYTOPENIA 1 0.0000
832 MUSCULAR WEAKNESS 2 0.0000
833 EYE IRRITATION 1 0.0000
834 NO ADVERSE EVENT 3 0.0000
835 SUICIDE ATTEMPT 1 0.0000
836 FEELING HOT 1 0.0000
837 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
838 VISUAL IMPAIRMENT 2 0.0000
839 INJECTION SITE ERYTHEMA 2 0.0000
840 BLOOD GLUCOSE INCREASED 3 0.0000
841 AMNESIA 1 0.0000
842 HYPOTENSION 3 0.0000
843 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
844 INJECTION SITE REACTION 1 0.0000
845 INJURY 1 0.0000
846 RESPIRATORY FAILURE 1 0.0000
847 CHRONIC KIDNEY DISEASE 1 0.0000
848 INJECTION SITE SWELLING 1 0.0000
849 INJECTION SITE PAIN 4 0.0000
850 PROSTATE CANCER 1 0.0000
851 CARDIAC ARREST 1 0.0000
852 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
853 RENAL IMPAIRMENT 1 0.0000
854 TOXICITY TO VARIOUS AGENTS 2 0.0000
855 URINARY TRACT INFECTION 2 0.0000
856 DRUG WITHDRAWAL SYNDROME 1 0.0000
857 ADVERSE DRUG REACTION 1 0.0000
858 SEPSIS 1 0.0000
859 THROMBOCYTOPENIA 1 0.0000
860 DISEASE PROGRESSION 1 0.0000
861 ACUTE KIDNEY INJURY 1 0.0000
862 HOSPITALISATION 1 0.0000
863 DEATH 3 0.0000